RAB8A a new biomarker for endometrial cancer?

World J Surg Oncol. 2014 Dec 4:12:371. doi: 10.1186/1477-7819-12-371.

Abstract

Background: We aimed to find different proteins between dendritic cells (DCs) and tumor antigen-pulsed DCs to help find a new biomarker for endometrial cancer (EC).

Methods: Mononuclear cells were isolated from cord blood and induced to DCs by cytokines. A comparative proteomic analysis was performed on DCs and tumor lysate-pulsed DCs by liquid chromatography with tandem mass spectrometry (LC-MS/MS). Differential proteins were identified by Western blot analysis.

Results: The expression of Ras-related protein Rab-8A (RAB8A) was found to be different in the in two kinds of cells. This phenomenon was also proven in endometrial cancer tissues.

Conclusions: RAB8A might be a new biomarker for endometrial cancer. Using LC-MS/MS to perform a comparative proteomic analysis about DCs and tumor lysate-pulsed DCs may help us to find new biomarker of cancer.

Publication types

  • Comparative Study

MeSH terms

  • Biomarkers, Tumor / metabolism*
  • Case-Control Studies
  • Cells, Cultured
  • Chromatography, Liquid
  • Dendritic Cells / cytology
  • Dendritic Cells / immunology
  • Dendritic Cells / metabolism*
  • Endometrial Neoplasms / immunology
  • Endometrial Neoplasms / metabolism*
  • Endometrial Neoplasms / pathology
  • Endometrium / metabolism*
  • Female
  • Fetal Blood / metabolism*
  • Humans
  • Lymphocyte Activation
  • Prognosis
  • Proteomics / methods*
  • Tandem Mass Spectrometry
  • rab GTP-Binding Proteins / metabolism*

Substances

  • Biomarkers, Tumor
  • RAB8A protein, human
  • rab GTP-Binding Proteins